Cardiothoracic
Feature
Societies dig in to EXCEL trial controversy
EACTS-ESC calls for evidence review and development of updated recommendations for left-main disease “as a matter of urgency.”
Conference Coverage
Health benefits of TAVR over SAVR sustained at 1 year
SAN FRANCISCO – This marks the first randomized trial to show a persistent, albeit modest, disease-specific health status advantage with TAVR at 6...
Conference Coverage
Volume directly tied to mitral valve procedure success
SAN FRANCISCO – The magic number for physicians is 35 cases per year.
Conference Coverage
Fibrinogen concentrate effective, safe for postop bleeding
SAN ANTONIO – Favored more in Europe than North America, fibrinogen concentrate was noninferior to cryoprecipitate for control of bleeding after...
Conference Coverage
Strong showing for TAVR after 5 years in PARTNER 2A
SAN FRANCISCO – In patients without acceptable transfemoral access, surgery may be the preferred alternative, Dr. Vinod H. Thourani said.
Conference Coverage
Race mismatch may affect survival in lung transplant setting
NEW ORLEANS – If it’s an option, clinicians should consider donor-to-recipient race compatibility.
Conference Coverage
Dermatitis associated with surgical implants merits conservative approach
NEW YORK – Even for persistent allergic dermatitis linked to a prosthetic device, explantation might not be helpful.
Feature
Revised CMS TAVR rules expected to widen access
Conference Coverage
Transcatheter pulmonary valve shows 5-year durability in postapproval study
LAS VEGAS – The 5-year follow-up of a U.S. postapproval study showed the expected durability of the Melody transcatheter pulmonary valve.
FDA/CDC
FDA updates warning about Impella RP System
From the Journals
Severe OSA increases cardiovascular risk after surgery
General anesthetics, sedatives, and postoperative analgesics are potent respiratory depressants that relax the upper airway dilator muscles and...